SAGE Similar Chart Price Prediction
The price of SAGE is predicted to go up -1.61%, based on the high correlation periods with IVT. The similarity of these two price pattern on the periods is 96.15%.
SAGE
IVT
Down: -1.61%Similarity: 96.15%
SAGE Revenue Forecast
SAGE EPS Forecast
SAGE FAQs
What is SAGE revenue forecast for next quarter？
What is SAGE eps forecast for next quarter？
SAGE Analyst's Forecast
Sumant Kulkarni
Canaccord Genuity
Hold
2025-02-12
Price Target
$9 → $8
Upside
+11.73%
Canaccord lowered the firm's price target on Sage Therapeutics (SAGE) to $8 from $9 and keeps a Hold rating on the shares. The firm said they reported its 4Q24 results after the close and Zurzuvae (zuranolone for post-partum depression/PPD) collaboration revenue came in at $11.4M versus our $12.1M estimate and consensus of $13.7M. Canaccord said they will continue to keep a close watch on Zurzuvae's performance given partner Biogen's (BIIB) unsolicited takeover approach, which Sage has decided not to accept, and Sage's ongoing strategic review.
David Amsellem
Piper Sandler
Buy
2025-01-02
Price Target
$26 → $9
Upside
+55.71%
Ritu Baral
TD Cowen
Hold
2024-11-21
Price Target
$10 → $9
Upside
+85.57%
